Database of value added generic drugs

Akane Kakuyama, Takenori Tamaki, Toshimi Iizuka, Hideto Ariumi, Tomoko Miyazaki, Miyoshi Kido, Yuji Yoshiyama, Megumi Kumai, Toshihiro Noda, Shigehiro Ohdo

Research output: Contribution to journalArticle

Abstract

To reduce the medical expense, the Japanese government is promoting generic drug use. Recently many "value added" generic drugs have been developed in Japan. These generic drugs are usually developed using innovative pharmaceutical technologies and such products achieve the goal of being more patient friendly by improving delivery system, flavor or ease of use. We have created a "Value added" Generic Drugs database to ensure accurate and appropriate use of these drugs. The purpose of this study was to show the utility of the database in clinical practice. In the present study, patients who had been treating their allergic rhinitis with Fluticasone Propionate Nasal Spray switched from the brand name to the "value added" generic drugs. We assessed changes in the patient's compliance and the therapeutic efficacy of the "value added" generic drugs. The therapeutic efficacy was maintained after switching to the "value added" drug. We suggested that the "value added" generic drug have an equivalent effect to the brand name, moreover, patient compliance was improved with the use of the "value added" drug. We can choose the generic drugs that more suit patients' needs by considering the "value added" generic drugs, so the "Value added" Generic Drugs database should become a useful source in clinical practice.

Original languageEnglish
Pages (from-to)55-59
Number of pages5
JournalOto-Rhino-Laryngology Tokyo
Volume53
Issue numberSUPPL. 2
Publication statusPublished - Aug 2010

Fingerprint

Generic Drugs
Databases
Pharmaceutical Databases
Patient Compliance
Names
Pharmaceutical Technology
Pharmaceutical Preparations
Nasal Sprays
Japan

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

Kakuyama, A., Tamaki, T., Iizuka, T., Ariumi, H., Miyazaki, T., Kido, M., ... Ohdo, S. (2010). Database of value added generic drugs. Oto-Rhino-Laryngology Tokyo, 53(SUPPL. 2), 55-59.

Database of value added generic drugs. / Kakuyama, Akane; Tamaki, Takenori; Iizuka, Toshimi; Ariumi, Hideto; Miyazaki, Tomoko; Kido, Miyoshi; Yoshiyama, Yuji; Kumai, Megumi; Noda, Toshihiro; Ohdo, Shigehiro.

In: Oto-Rhino-Laryngology Tokyo, Vol. 53, No. SUPPL. 2, 08.2010, p. 55-59.

Research output: Contribution to journalArticle

Kakuyama, A, Tamaki, T, Iizuka, T, Ariumi, H, Miyazaki, T, Kido, M, Yoshiyama, Y, Kumai, M, Noda, T & Ohdo, S 2010, 'Database of value added generic drugs', Oto-Rhino-Laryngology Tokyo, vol. 53, no. SUPPL. 2, pp. 55-59.
Kakuyama A, Tamaki T, Iizuka T, Ariumi H, Miyazaki T, Kido M et al. Database of value added generic drugs. Oto-Rhino-Laryngology Tokyo. 2010 Aug;53(SUPPL. 2):55-59.
Kakuyama, Akane ; Tamaki, Takenori ; Iizuka, Toshimi ; Ariumi, Hideto ; Miyazaki, Tomoko ; Kido, Miyoshi ; Yoshiyama, Yuji ; Kumai, Megumi ; Noda, Toshihiro ; Ohdo, Shigehiro. / Database of value added generic drugs. In: Oto-Rhino-Laryngology Tokyo. 2010 ; Vol. 53, No. SUPPL. 2. pp. 55-59.
@article{543f69175d024cedb40afdce65f806cf,
title = "Database of value added generic drugs",
abstract = "To reduce the medical expense, the Japanese government is promoting generic drug use. Recently many {"}value added{"} generic drugs have been developed in Japan. These generic drugs are usually developed using innovative pharmaceutical technologies and such products achieve the goal of being more patient friendly by improving delivery system, flavor or ease of use. We have created a {"}Value added{"} Generic Drugs database to ensure accurate and appropriate use of these drugs. The purpose of this study was to show the utility of the database in clinical practice. In the present study, patients who had been treating their allergic rhinitis with Fluticasone Propionate Nasal Spray switched from the brand name to the {"}value added{"} generic drugs. We assessed changes in the patient's compliance and the therapeutic efficacy of the {"}value added{"} generic drugs. The therapeutic efficacy was maintained after switching to the {"}value added{"} drug. We suggested that the {"}value added{"} generic drug have an equivalent effect to the brand name, moreover, patient compliance was improved with the use of the {"}value added{"} drug. We can choose the generic drugs that more suit patients' needs by considering the {"}value added{"} generic drugs, so the {"}Value added{"} Generic Drugs database should become a useful source in clinical practice.",
author = "Akane Kakuyama and Takenori Tamaki and Toshimi Iizuka and Hideto Ariumi and Tomoko Miyazaki and Miyoshi Kido and Yuji Yoshiyama and Megumi Kumai and Toshihiro Noda and Shigehiro Ohdo",
year = "2010",
month = "8",
language = "English",
volume = "53",
pages = "55--59",
journal = "Oto-Rhino-Laryngology Tokyo",
issn = "0386-9687",
publisher = "Society of Oto-Rhino-Laryngology Tokyo",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Database of value added generic drugs

AU - Kakuyama, Akane

AU - Tamaki, Takenori

AU - Iizuka, Toshimi

AU - Ariumi, Hideto

AU - Miyazaki, Tomoko

AU - Kido, Miyoshi

AU - Yoshiyama, Yuji

AU - Kumai, Megumi

AU - Noda, Toshihiro

AU - Ohdo, Shigehiro

PY - 2010/8

Y1 - 2010/8

N2 - To reduce the medical expense, the Japanese government is promoting generic drug use. Recently many "value added" generic drugs have been developed in Japan. These generic drugs are usually developed using innovative pharmaceutical technologies and such products achieve the goal of being more patient friendly by improving delivery system, flavor or ease of use. We have created a "Value added" Generic Drugs database to ensure accurate and appropriate use of these drugs. The purpose of this study was to show the utility of the database in clinical practice. In the present study, patients who had been treating their allergic rhinitis with Fluticasone Propionate Nasal Spray switched from the brand name to the "value added" generic drugs. We assessed changes in the patient's compliance and the therapeutic efficacy of the "value added" generic drugs. The therapeutic efficacy was maintained after switching to the "value added" drug. We suggested that the "value added" generic drug have an equivalent effect to the brand name, moreover, patient compliance was improved with the use of the "value added" drug. We can choose the generic drugs that more suit patients' needs by considering the "value added" generic drugs, so the "Value added" Generic Drugs database should become a useful source in clinical practice.

AB - To reduce the medical expense, the Japanese government is promoting generic drug use. Recently many "value added" generic drugs have been developed in Japan. These generic drugs are usually developed using innovative pharmaceutical technologies and such products achieve the goal of being more patient friendly by improving delivery system, flavor or ease of use. We have created a "Value added" Generic Drugs database to ensure accurate and appropriate use of these drugs. The purpose of this study was to show the utility of the database in clinical practice. In the present study, patients who had been treating their allergic rhinitis with Fluticasone Propionate Nasal Spray switched from the brand name to the "value added" generic drugs. We assessed changes in the patient's compliance and the therapeutic efficacy of the "value added" generic drugs. The therapeutic efficacy was maintained after switching to the "value added" drug. We suggested that the "value added" generic drug have an equivalent effect to the brand name, moreover, patient compliance was improved with the use of the "value added" drug. We can choose the generic drugs that more suit patients' needs by considering the "value added" generic drugs, so the "Value added" Generic Drugs database should become a useful source in clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=78349241726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78349241726&partnerID=8YFLogxK

M3 - Article

VL - 53

SP - 55

EP - 59

JO - Oto-Rhino-Laryngology Tokyo

JF - Oto-Rhino-Laryngology Tokyo

SN - 0386-9687

IS - SUPPL. 2

ER -